This parliamentary question seeks clarification on whether liver and kidney function assessments are conducted before and during treatment with medications known to potentially cause liver or kidney damage. The answer confirms that this is standard clinical practice.

AnsweredQoN 6015Legislative Council
Asked
20 March 2008
Portfolio
Health

QuestionView source ↗

(2) If no to (1), why not?
(3) If yes to (1), are follow-up liver and kidney function screens performed periodically to monitor liver and/or kidney function?

AnswerView source ↗

Answered
6 May 2008
Responded by
Minister for Child Protection representing the Minister for Health
Response time
47 days
(1 - 3) It is normal clinical practice for a patient's liver or kidney function to be assessed prior to commencing treatment on a medicine with a side effect known to have a higher risk of causing kidney or liver damage. Periodic follow up assessments of kidney and liver functions are undertaken if a patient remains on the medicine.
Notice: This document is created or edited using unregistered or evaluation copy of rtLib valid for testing or development purposes only. To use it for productive or any other purposes please register it. You may purchase the license on
http://www.rtlib.com

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more